BRIEF-Astrazeneca says U.S. FDA approved BEVESPI aerosphere inhalation aerosol indicated for treatment of patients with chronic obstructive pulmonary disease
* US FDA approved BEVESPI aerosphere inhalation aerosol
indicated for treatment of patients with chronic obstructive
No comments:
Post a Comment